Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2006-11-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRENOBLE (38100), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE MALHERBE PERROT : revenue, balance sheet and financial ratios
PHARMACIE MALHERBE PERROT is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRENOBLE (38100),
this company of category PME
shows in 2024 a net income positive of 316 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE MALHERBE PERROT (SIREN 492827795)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
316 233 €
183 026 €
258 600 €
173 348 €
318 355 €
188 023 €
185 308 €
165 457 €
194 727 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE MALHERBE PERROT generates positive net income of 316 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 195 k€ -> 316 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
316 233 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 135%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
134.713%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.425%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
136.161
384.944
273.818
199.856
217.029
289.962
193.973
176.556
134.713
Financial autonomy
37.294
18.161
23.261
28.458
27.123
21.66
28.155
29.347
34.425
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
134.712024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-5 pts over 3 years
In 2024, the debt ratio of PHARMACIE MALHERBE PERROT (134.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.42%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE MALHERBE PERROT (34.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 147.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
161.217
174.41
196.052
167.63
273.695
126.317
106.483
134.796
147.383
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
147.382024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average+15 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE MALHERBE PERROT (147.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE MALHERBE PERROT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE MALHERBE PERROT is estimated at
4 414 846 €
(range 3 074 429€ - 6 604 862€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3074k€4414k€6604k€
4 414 846 €Range: 3 074 429€ - 6 604 862€
NAF 5 année 2024
Valuation method used
Net Income Multiple
316 233 €
×
14.0x
=4 414 846 €
Range: 3 074 429€ - 6 604 863€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE MALHERBE PERROT with other companies in the same sector:
Frequently asked questions about PHARMACIE MALHERBE PERROT
What is the revenue of PHARMACIE MALHERBE PERROT ?
The revenue of PHARMACIE MALHERBE PERROT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE MALHERBE PERROT profitable?
Yes, PHARMACIE MALHERBE PERROT generated a net profit of 316 k€ in 2024.
Where is the headquarters of PHARMACIE MALHERBE PERROT ?
The headquarters of PHARMACIE MALHERBE PERROT is located in GRENOBLE (38100), in the department Isere.
Where to find the tax return of PHARMACIE MALHERBE PERROT ?
The tax return of PHARMACIE MALHERBE PERROT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE MALHERBE PERROT operate?
PHARMACIE MALHERBE PERROT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart